Assignee
SAGE THERAPEUTICS INC
US·91 granted patents·126 pending applications·841 citations·filing 2012–2025
Top patents by PatentIndex Score
217 records- 0199US11530237B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·9 cites·4 claims
- 0299US11149057B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Oct 19, 2021·9 cites·33 claims
- 0399US10723758B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·20 cites·2 claims
- 0499US10246482B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 2, 2019·38 cites·85 claims
- 0598US11905309B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Feb 20, 2024·5 cites·18 claims
- 0698US11878995B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 23, 2024·5 cites·16 claims
- 0798US11613556B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 28, 2023·6 cites·20 claims
- 0898US11542297B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 3, 2023·9 cites·28 claims
- 0998US11241446B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·12 cites·15 claims
- 1098US11149054B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Oct 19, 2021·14 cites·8 claims
- 1198US11111266B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Sep 7, 2021·15 cites·25 claims
- 1298US11104701B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Aug 31, 2021·16 cites·24 claims
- 1398US10870677B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·13 cites·1 claims
- 1498US10696712B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jun 30, 2020·21 cites·3 claims
- 1598US10259840B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 16, 2019·30 cites·3 claims
- 1698US10227375B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·33 cites·4 claims
- 1798US9512165B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·71 cites·2 claims
- 1897US12060386B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2023·Granted Aug 13, 2024·3 cites·10 claims
- 1997US11926646B2C7 substituted oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 12, 2024·5 cites·11 claims
- 2097US11884697B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·6 cites·27 claims
- 2197US11780875B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Oct 10, 2023·4 cites·20 claims
- 2297US11732000B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Aug 22, 2023·6 cites·12 claims
- 2397US11643434B2Neuroactive steroids and compositions thereofSAGE THERAPEUTICS INC·Filed 2020·Granted May 9, 2023·9 cites·25 claims
- 2497US11498940B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·8 cites·30 claims
- 2597US11407782B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Aug 9, 2022·5 cites·22 claims
- 2697US11236121B2Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2017·Granted Feb 1, 2022·23 cites·5 claims
- 2797US10822370B219-nor neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Nov 3, 2020·13 cites·24 claims
- 2897US10774108B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2015·Granted Sep 15, 2020·12 cites·18 claims
- 2997US10759828B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Sep 1, 2020·15 cites·1 claims
- 3097US10745436B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Aug 18, 2020·9 cites·30 claims
- 3197US10342810B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·17 cites·16 claims
- 3297US10201550B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·23 cites·2 claims
- 3397US10172871B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·20 cites·12 claims
- 3497US9725481B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Aug 8, 2017·46 cites·26 claims
- 3597US9365611B219-NOR neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·49 cites·25 claims
- 3696US12129276B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·2 cites·20 claims
- 3796US11945836B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·3 cites·20 claims
- 3896US11851457B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·4 cites·18 claims
- 3996US11344563B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted May 31, 2022·8 cites·20 claims
- 4096US11279730B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Mar 22, 2022·5 cites·13 claims
- 4196US11147877B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Oct 19, 2021·8 cites·12 claims
- 4296US11046728B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·8 cites·14 claims
- 4395US12268697B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2024·Granted Apr 8, 2025·1 cites·4 claims
- 4495US12180247B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·2 cites·12 claims
- 4595US12048706B2Methods of treating epilepsy or status epilepticusSAGE THERAPEUTICS INC·Filed 2022·Granted Jul 30, 2024·3 cites·4 claims
- 4695US11884696B2Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·4 cites·19 claims
- 4795US11667668B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2021·Granted Jun 6, 2023·3 cites·8 claims
- 4895US11634453B2Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Apr 25, 2023·8 cites·46 claims
- 4995US11426417B2Neuroactive steroid formulations and methods of treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Aug 30, 2022·8 cites·6 claims
- 5095US10329320B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jun 25, 2019·18 cites·25 claims
Showing the top 50 of 217 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SAGE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →